News und Analysen
![EQS-Adhoc: TRATON SE announces preliminary 3M 2023 results](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
EQS-Adhoc: TRATON SE announces preliminary 3M 2023 results
EQS-Adhoc: TRATON SE announces preliminary 3M 2023 results
![EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
![EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Releases Annual Report and Announces Dividend Proposal](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Releases Annual Report and Announces Dividend Proposal
EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Releases Annual Report and Announces Dividend Proposal
![EQS-Adhoc: Dermapharm Holding SE: 2022 dividend](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
EQS-Adhoc: Dermapharm Holding SE: 2022 dividend
EQS-Adhoc: Dermapharm Holding SE: 2022 dividend
![EQS-Adhoc: HENSOLDT AG: Oliver Dörre to succeed Thomas Müller in 2024 as Chairman of the Management Board as part of an early and long-term succession plan](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
EQS-Adhoc: HENSOLDT AG: Oliver Dörre to succeed Thomas Müller in 2024 as Chairman of the Management Board as part of an early and long-term succession plan
EQS-Adhoc: HENSOLDT AG: Oliver Dörre to succeed Thomas Müller in 2024 as Chairman of the Management Board as part of an early and long-term succession plan
![EQS-News: HENSOLDT AG: Oliver Dörre to succeed Thomas Müller in 2024 as Chairman of the Management Board as part of an early and long-term succession plan](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
EQS-News: HENSOLDT AG: Oliver Dörre to succeed Thomas Müller in 2024 as Chairman of the Management Board as part of an early and long-term succession plan
EQS-News: HENSOLDT AG: Oliver Dörre to succeed Thomas Müller in 2024 as Chairman of the Management Board as part of an early and long-term succession plan
![EQS-News: Instone Real Estate Group SE achieves good result in a difficult environment with a largely stable earnings outlook for 2023](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
EQS-News: Instone Real Estate Group SE achieves good result in a difficult environment with a largely stable earnings outlook for 2023
EQS-News: Instone Real Estate Group SE achieves good result in a difficult environment with a largely stable earnings outlook for 2023
![EQS-News: SYNLAB AG: SYNLAB delivers robust underlying growth in FY 2022](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
EQS-News: SYNLAB AG: SYNLAB delivers robust underlying growth in FY 2022
EQS-News: SYNLAB AG: SYNLAB delivers robust underlying growth in FY 2022
![EQS-Adhoc: SYNLAB AG: Extension of the appointment of Mathieu Floreani as CEO and Sami Badarani as CFO](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
EQS-Adhoc: SYNLAB AG: Extension of the appointment of Mathieu Floreani as CEO and Sami Badarani as CFO
EQS-Adhoc: SYNLAB AG: Extension of the appointment of Mathieu Floreani as CEO and Sami Badarani as CFO
![EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
![EQS-Adhoc: SYNLAB AG: Non-binding expression of interest by Cinven for acquisition offer at an indicative offer price of 10.00 Euro per SYNLAB share](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
EQS-Adhoc: SYNLAB AG: Non-binding expression of interest by Cinven for acquisition offer at an indicative offer price of 10.00 Euro per SYNLAB share
EQS-Adhoc: SYNLAB AG: Non-binding expression of interest by Cinven for acquisition offer at an indicative offer price of 10.00 Euro per SYNLAB share
![EQS-Adhoc: New Work SE Executive Board proposes an increased regular dividend and payment of a special dividend](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
EQS-Adhoc: New Work SE Executive Board proposes an increased regular dividend and payment of a special dividend
EQS-Adhoc: New Work SE Executive Board proposes an increased regular dividend and payment of a special dividend
![EQS-News: HENSOLDT grows significantly in 2022 financial year and stands ready as strong technology partner for the “Zeitenwende”](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
EQS-News: HENSOLDT grows significantly in 2022 financial year and stands ready as strong technology partner for the “Zeitenwende”
EQS-News: HENSOLDT grows significantly in 2022 financial year and stands ready as strong technology partner for the “Zeitenwende”
![EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Remains on the Path to Success Even in a Year of Global Crisis](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Remains on the Path to Success Even in a Year of Global Crisis
EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Remains on the Path to Success Even in a Year of Global Crisis
![EQS-News: SYNLAB AG: SYNLAB reports trading update for FY 2022 and revises FY 2023 guidance from lower COVID-19 testing](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
EQS-News: SYNLAB AG: SYNLAB reports trading update for FY 2022 and revises FY 2023 guidance from lower COVID-19 testing
EQS-News: SYNLAB AG: SYNLAB reports trading update for FY 2022 and revises FY 2023 guidance from lower COVID-19 testing
![EQS-Adhoc: SYNLAB AG: SYNLAB revises FY 2023 guidance from lower COVID-19 testing volumes](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
EQS-Adhoc: SYNLAB AG: SYNLAB revises FY 2023 guidance from lower COVID-19 testing volumes
EQS-Adhoc: SYNLAB AG: SYNLAB revises FY 2023 guidance from lower COVID-19 testing volumes
![EQS-News: DWS 2022: Solid Results and Increasing Management Fees in Extraordinarily Challenging Environment](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
EQS-News: DWS 2022: Solid Results and Increasing Management Fees in Extraordinarily Challenging Environment
EQS-News: DWS 2022: Solid Results and Increasing Management Fees in Extraordinarily Challenging Environment
![EQS-News: ABOUT YOU Holding SE: ABOUT YOU Delivers Solid Growth in Q3 2022/2023 despite Continued Market Volatility](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
EQS-News: ABOUT YOU Holding SE: ABOUT YOU Delivers Solid Growth in Q3 2022/2023 despite Continued Market Volatility
EQS-News: ABOUT YOU Holding SE: ABOUT YOU Delivers Solid Growth in Q3 2022/2023 despite Continued Market Volatility
![EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma
![EQS-News: SYNLAB AG: Portuguese competition authority investigating the local laboratory diagnostics market – SYNLAB’s operations in Portugal included in such investigation](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
EQS-News: SYNLAB AG: Portuguese competition authority investigating the local laboratory diagnostics market – SYNLAB’s operations in Portugal included in such investigation
EQS-News: SYNLAB AG: Portuguese competition authority investigating the local laboratory diagnostics market – SYNLAB’s operations in Portugal included in such investigation
![EQS-Adhoc: SYNLAB AG: Proceedings of the Portuguese Competition Authority against entities of SYNLAB](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
EQS-Adhoc: SYNLAB AG: Proceedings of the Portuguese Competition Authority against entities of SYNLAB
EQS-Adhoc: SYNLAB AG: Proceedings of the Portuguese Competition Authority against entities of SYNLAB
![EQS-News: HENSOLDT AG accelerates growth and raises targets](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
EQS-News: HENSOLDT AG accelerates growth and raises targets
EQS-News: HENSOLDT AG accelerates growth and raises targets
![EQS-News: DWS announces Strategic Ambition and Financial Targets for 2025](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
EQS-News: DWS announces Strategic Ambition and Financial Targets for 2025
EQS-News: DWS announces Strategic Ambition and Financial Targets for 2025
![EQS-Adhoc: DWS Group GmbH & Co. KGaA: Proposed dividend pay-out](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Proposed dividend pay-out
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Proposed dividend pay-out
![EQS-News: Dermapharm Holding SE successfully maintains growth trend as planned](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
EQS-News: Dermapharm Holding SE successfully maintains growth trend as planned
EQS-News: Dermapharm Holding SE successfully maintains growth trend as planned